What is the purpose of this trial?
The study is funded by the National Heart, Lung, and Blood Institute, with additional infrastructure support provided by the National Institute of Allergy and Infectious Diseases.
People infected with HIV are at risk for cardiovascular disease (CVD). This study will evaluate the use of pitavastatin to reduce the risk of CVD in adults infected with HIV who are on antiretroviral therapy (ART).
Ages: 40 - 75 years
Massachusetts General Hospital
Start Date: 02/19/2015
End Date: 04/01/2020
Last Updated: 05/13/2018
Study HIC#: 1501015241